Saralasin
| Saralasin | ||
|---|---|---|
| 
 | 
||
| Structural formula | ||
| Mass / length primary structure | 8 amino acids | |
| Identifier | ||
| External IDs | 
  | 
|
| Drug information | ||
| ATC code | C09 CA | |
| Drug class | Angiotensin II antagonist | |
Saralasin is an angiotensin II inhibitor or competitive antagonist . It is an angiotensin-II analog that contains sarcosine -1 and alanine -8 - hence the name (sarcosine, alanine, angiotensin). The active ingredient plays a role in the area of hypertension and aldosterone secretion .
literature
- Th. Philipp, H. Zschiedrich and A. Distler: Influence of the angiotensin II antagonist Saralasin on hemodynamics in patients with renovascular hypertension . In: Clinical weekly . Volume 55, Issue 18 / September 1977 on-line
 - Library query on Saralasin